<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kim D</submitter><funding>NHLBI NIH HHS</funding><funding>Foundation for the National Institutes of Health</funding><pagination>2652-2661</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12810971</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>53(4)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>Myocardial perfusion imaging (MPI) is frequently used to improve cardiac risk prediction in patients undergoing non-cardiac surgery. However, the data supporting this practice is derived from single center studies and predates current therapy for coronary artery disease (CAD). We evaluated the association between pre-operative testing indication and outcomes as well as predictors of death or myocardial infarction (MI) in these patients.&lt;h4>Methods&lt;/h4>We include patients from the international, multicenter REFINE-SPECT registry (13 sites). Based on referral indication, patients were classified as pre-operative testing indications and non-pre-operative testing. We evaluated the associations between pre-operative testing and incidence of death or MI. We then evaluated associa</pubmed_abstract><journal>European journal of nuclear medicine and molecular imaging</journal><pubmed_title>Risk stratification with pre-operative myocardial perfusion imaging.</pubmed_title><pmcid>PMC12810971</pmcid><funding_grant_id>R35HL161195</funding_grant_id><funding_grant_id>R35 HL161195</funding_grant_id><funding_grant_id>R01HL089765</funding_grant_id><funding_grant_id>R01 HL089765</funding_grant_id><pubmed_authors>Halcox J</pubmed_authors><pubmed_authors>Kim D</pubmed_authors><pubmed_authors>Di Carli MF</pubmed_authors><pubmed_authors>Miller RJH</pubmed_authors><pubmed_authors>Sharir T</pubmed_authors><pubmed_authors>Sinusas AJ</pubmed_authors><pubmed_authors>Hauser MT</pubmed_authors><pubmed_authors>Bateman TM</pubmed_authors><pubmed_authors>Ruddy TD</pubmed_authors><pubmed_authors>Berman DS</pubmed_authors><pubmed_authors>Dey D</pubmed_authors><pubmed_authors>Einstein AJ</pubmed_authors><pubmed_authors>Dorbala S</pubmed_authors><pubmed_authors>Kaufmann PA</pubmed_authors><pubmed_authors>Fish MB</pubmed_authors><pubmed_authors>Acampa W</pubmed_authors><pubmed_authors>Builoff V</pubmed_authors><pubmed_authors>Miller EJ</pubmed_authors><pubmed_authors>Slomka PJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Risk stratification with pre-operative myocardial perfusion imaging.</name><description>&lt;h4>Purpose&lt;/h4>Myocardial perfusion imaging (MPI) is frequently used to improve cardiac risk prediction in patients undergoing non-cardiac surgery. However, the data supporting this practice is derived from single center studies and predates current therapy for coronary artery disease (CAD). We evaluated the association between pre-operative testing indication and outcomes as well as predictors of death or myocardial infarction (MI) in these patients.&lt;h4>Methods&lt;/h4>We include patients from the international, multicenter REFINE-SPECT registry (13 sites). Based on referral indication, patients were classified as pre-operative testing indications and non-pre-operative testing. We evaluated the associations between pre-operative testing and incidence of death or MI. We then evaluated associa</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Mar</publication><modification>2026-07-16T09:42:19.337Z</modification><creation>2026-07-09T10:46:52.39Z</creation></dates><accession>S-EPMC12810971</accession><cross_references><pubmed>41143983</pubmed><doi>10.1007/s00259-025-07530-6</doi></cross_references></HashMap>